免疫增生性疾病的临床试验
总计144583个结果
-
Klinikum StuttgartUniversity Hospital Freiburg终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人
-
EusaPharma (UK) Limited终止
-
Novartis Pharmaceuticals完全的
-
Genentech, Inc.完全的
-
GlaxoSmithKline完全的
-
National Cancer Institute (NCI)完全的
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Stanford University终止
-
Ludwig Institute for Cancer ResearchJohns Hopkins University撤销
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Inje University; Severance Hospital未知
-
Human Genome Sciences Inc.完全的
-
New Approaches to Brain Tumor Therapy ConsortiumNational Cancer Institute (NCI)完全的
-
Royal Marsden NHS Foundation Trust完全的
-
Enzon Pharmaceuticals, Inc.完全的
-
A.O. Ospedale Papa Giovanni XXIIIRegional Hospital of Bolzano终止
-
National Research Center for Hematology, Russia招聘中
-
Hrain Biotechnology Co., Ltd.Second Affiliated Hospital of Nanchang University招聘中
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC; Seagen Inc.招聘中
-
St. Petersburg State Pavlov Medical University招聘中
-
University College, LondonUniversity of Miami; Takeda; European Organisation for Research and Treatment of Cancer - EORTC; Canadian Cancer Trials Group 和其他合作者招聘中
-
University of ExeterUniversity of Bristol; Gloucestershire Hospitals NHS Foundation Trust招聘中